Arcturus COVID-19 vaccine may refer to: ARCT-021 ARCT-154 This disambiguation page lists articles associated with the title Arcturus COVID-19 vaccine...

June 2020. In response to the COVID-19 pandemic, Arcturus partnered with Duke–NUS Medical School to develop a COVID-19 vaccine using a combination of self-replicating...

VBC-COV19-154 in Vietnam, is a COVID-19 vaccine candidate developed by Arcturus Therapeutics. For its development, Arcturus collaborated with Vinbiocare...

ARCT-021, also known as LUNAR-COV19, is a COVID-19 vaccine candidate developed by Arcturus Therapeutics. It requires the intramuscular injection with a...

COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy...

vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were...

COVID-19 Immunization Program Management Organizational Structure was formed on October 26, 2020, to facilitate the distribution of COVID-19 vaccines...

COVID-19 - 20 April 2023". World Health Organization. Retrieved 21 April 2023. Hagan, Rachel (20 April 2023). "First person dies with Arcturus Covid variant...

subvariants of BA.5 called BQ.1 and BQ.1.1 have emerged. Three doses of a COVID-19 vaccine provide protection against severe disease and hospitalisation caused...

scientists from Singapore's Duke-NUS Medical School testing a COVID-19 vaccine from Arcturus Therapeutics would start human trials in August. The National...